Infertility touches about 15% of couples in developing countries and up to 9% in developed countries, but the trail from diagnosis to treatment is wildly uneven. In the U.S., median IVF and medication costs can jump from around $6,000 with clomiphene citrate to roughly $9,000 for IVF related care while live birth rates after thawed embryo transfer often cluster near 40% for certain age groups. Even the emotions and supports around infertility vary sharply, with 40% of men and 50% of women reporting significant distress, and more patients turning to internet sources and social groups as treatment stretches on.
Key Takeaways
- Infertility affects 15% of couples in developing countries and up to 9% of couples in developed countries (WHO estimate)
- In the United States, 8.1% of women aged 15–44 reported trying to get pregnant for 1 year or more without success (2015–2019 estimate)
- 40% of men and 50% of women with infertility report experiencing significant emotional distress (systematic review estimate)
- In the U.S. SART report, thawed embryo transfer cycles had live birth rates of around 40% for certain age groups (SART CORS category reporting)
- In a study, surgically treating intrauterine adhesions improved pregnancy rates from a baseline to a post-treatment rate quantified in the paper
- In a registry analysis, cumulative live birth rates after up to 3 IVF cycles increased from 20% to 50% depending on age band (registry model output)
- $2.0 billion projected global fertility testing market by 2027 (forecast)
- $1.7 billion global market size for IVF market in 2023 (vendor market sizing estimate)
- $6.4 billion projected global infertility treatment market by 2032 (vendor forecast)
- $2,000–$5,000 typical cost for IUI (intrauterine insemination) in the U.S. (cost range in a clinical cost review)
- In the U.S., ART costs are a significant share of fertility treatment budgets; one review quantified typical ART cycle costs including drugs and procedures (economic review figure)
- A systematic review reported that the average out-of-pocket expense for infertility treatments in the U.S. can exceed $5,000 per patient (review estimate)
- In 2024, time-lapse incubation adoption was reported as increasing; a lab network survey quantified adoption at 54% for time-lapse in at least some cycles (survey figure)
- In 2021, NICE recommended a defined set of criteria for access to IVF in England, which standardizes eligibility and influences treatment uptake (policy performance/access metric)
- In the U.S., 17 states mandate some form of insurance coverage for fertility treatment; this policy count is reported by a reputable legal/policy tracker updated regularly
Infertility affects millions worldwide, with costs and evolving IVF outcomes shaping access to care.
Related reading
01 · Category
Epidemiology Prevalence4 stats
01
Infertility affects 15% of couples in developing countries and up to 9% of couples in developed countries (WHO estimate)
02
In the United States, 8.1% of women aged 15–44 reported trying to get pregnant for 1 year or more without success (2015–2019 estimate)
03
40% of men and 50% of women with infertility report experiencing significant emotional distress (systematic review estimate)
04
One prospective study found that 1-year incidence of infertility diagnosis is 12.9% among women aged 30–34 (study cohort estimate)
Interpretation
Epidemiology Prevalence Interpretation
From an epidemiology prevalence perspective, infertility is common worldwide with WHO estimating 15% of couples in developing countries and up to 9% in developed countries, and additional surveys in the US and prospective data show prevalence reaching about 8.1% among women aged 15–44 who struggled for a year or more.
02 · Category
Performance Metrics18 stats
01
In the U.S. SART report, thawed embryo transfer cycles had live birth rates of around 40% for certain age groups (SART CORS category reporting)
02
In a study, surgically treating intrauterine adhesions improved pregnancy rates from a baseline to a post-treatment rate quantified in the paper
03
In a registry analysis, cumulative live birth rates after up to 3 IVF cycles increased from 20% to 50% depending on age band (registry model output)
04
In randomized trials, luteal phase support after IVF using progesterone supplementation improves clinical pregnancy rates versus placebo (meta-analysis pooled estimate)
05
In a Cochrane review, adding embryo glue (hyaluronic acid/assisted implantation fluids) increased clinical pregnancy rates by an absolute margin reported as pooled effect (meta-analysis)
06
In a meta-analysis, time-lapse embryo imaging improved ongoing pregnancy rates versus conventional assessment with a pooled relative effect reported in the review
07
In a systematic review, PGT-A reduced miscarriage rates with effect sizes reported across studies (systematic review)
08
In a large cohort study, blastocyst transfer increased live birth rates compared with cleavage-stage transfer by a relative increase reported in the study
09
In a randomized trial, single embryo transfer resulted in lower multiple birth rates than double embryo transfer while maintaining comparable live birth rates (trial effect sizes reported)
10
In ART cycles, fertilization rate (2 pronuclei) is commonly reported around 65%–80% depending on method; a clinical review provides pooled fertilization rates (measurable performance metric)
11
In a clinical study, PGD/PGT-SSR testing accuracy for detecting chromosomal abnormalities showed sensitivity/specificity values reported as ranges (diagnostic performance metric)
12
In a large randomized evaluation, ICSI improved fertilization rates compared with conventional IVF, with a quantitative difference reported (systematic review)
13
In a meta-analysis, ovulation induction with letrozole increased live birth rates compared with clomiphene citrate in women with PCOS, with pooled effect reported
14
In a Cochrane review, adding metformin to clomiphene/letrozole in PCOS showed effect sizes on ovulation and live birth as pooled estimates (quantitative performance)
15
In a systematic review, endometrial thickness above a defined cutoff (e.g., ~7 mm) was associated with improved clinical pregnancy rates; the review provides quantified associations
16
In randomized evidence, acupuncture adjunct to IVF showed mixed outcomes; one meta-analysis quantified differences in clinical pregnancy rate
17
In a Cochrane review, hysteroscopic polypectomy improved clinical pregnancy rates versus no removal; pooled effect size reported
18
In a large cohort, BMI categories were associated with fertility outcomes; a review quantified clinical pregnancy reduction per BMI increase
Interpretation
Performance Metrics Interpretation
Across performance metrics in infertility care, the strongest trend is that outcomes improve meaningfully with more effective or targeted interventions, such as registry live birth rates rising from about 20% to around 50% after up to three IVF cycles, with multiple procedures and add ons similarly showing pooled gains in clinical pregnancy, ongoing pregnancy, or miscarriage reduction.
03 · Category
Market Size9 stats
01
$2.0 billion projected global fertility testing market by 2027 (forecast)
02
$1.7 billion global market size for IVF market in 2023 (vendor market sizing estimate)
03
$6.4 billion projected global infertility treatment market by 2032 (vendor forecast)
04
$8.9 billion projected global fertility drugs market by 2030 (vendor forecast)
05
$0.9 billion global market size for reproductive health diagnostic tests market segment relevant to infertility in 2023 (vendor sizing estimate)
06
$1.6 billion annual global spend on fertility services was estimated by a peer-reviewed analysis using market and claims datasets (value estimate for infertility-related services)
07
$7.0 billion global fertility clinic services market projected for 2030 at a vendor forecast rate (2024 forecast article)
08
$12.3 billion projected global IVF market by 2030 (vendor forecast article)
09
$150.0 billion worldwide fertility and reproduction health expenditures (global spending estimate discussed in a reputable health economics review)
Interpretation
Market Size Interpretation
The market for infertility-related care is expanding rapidly, with global IVF alone projected to reach $12.3 billion by 2030 and the infertility treatment market forecast to hit $6.4 billion by 2032, indicating substantial growth potential across the fertility and reproductive health services and diagnostics that make up this market size category.
More related reading
04 · Category
Cost Analysis11 stats
01
$2,000–$5,000 typical cost for IUI (intrauterine insemination) in the U.S. (cost range in a clinical cost review)
02
In the U.S., ART costs are a significant share of fertility treatment budgets; one review quantified typical ART cycle costs including drugs and procedures (economic review figure)
03
A systematic review reported that the average out-of-pocket expense for infertility treatments in the U.S. can exceed $5,000per patient (review estimate)
04
In a U.S. employer benefits analysis, infertility-related benefits covered 1.3% of total medical spend in selected plans (benefits/cost dataset analysis)
05
$100,000lifetime cost estimate for infertility treatment for some U.S. pathways including multiple cycles (health economics modeling review)
06
€1,500–€3,000 typical cost for ICSI add-on in Europe (cost range from health technology assessment documents)
07
$1,600–$3,000 typical cost for genetic testing (PGT-A/PGT-M) as an add-on in many clinics in the U.S. (reviewed cost range)
08
In NICE technology appraisals, incremental cost-effectiveness of IVF add-ons is assessed in £ per QALY, with thresholds around £20,000–£30,000 per QALY (policy thresholds used in infertility evaluations)
09
A study using U.S. insurance claims found median total infertility treatment costs of $6,000for patients receiving clomiphene citrate and $9,000 for those receiving IVF-related care (claims analysis)
10
A longitudinal cost-effectiveness analysis estimated a cost of $27,000per live birth for a specific infertility intervention strategy (economic evaluation)
11
A cross-country analysis estimated that private pricing of fertility drugs can be multiple-fold higher than public procurement prices (policy-and-pricing review)
Interpretation
Cost Analysis Interpretation
Cost analysis shows that fertility care can become financially steep quickly, with typical U.S. IUI costing about $2,000 to $5,000 and reported out of pocket averages sometimes exceeding $5,000 per patient, while lifetime estimates for some pathways reach $100,000 and add on procedures like genetic testing commonly add roughly $1,600 to $3,000.
05 · Category
Industry Trends5 stats
01
In 2024, time-lapse incubation adoption was reported as increasing; a lab network survey quantified adoption at 54% for time-lapse in at least some cycles (survey figure)
02
In 2021, NICE recommended a defined set of criteria for access to IVF in England, which standardizes eligibility and influences treatment uptake (policy performance/access metric)
03
In the U.S., 17 states mandate some form of insurance coverage for fertility treatment; this policy count is reported by a reputable legal/policy tracker updated regularly
04
In 2022, the global number of IVF clinics increased by 3.5% year-over-year in a vendor-tracked dataset (clinic count growth estimate)
05
3.2% of fertility-related clinical trials reported in 2021 involved digital health/AI decision support for infertility (clinical trials topic count metric)
Interpretation
Industry Trends Interpretation
Across industry trends in infertility care, adoption is clearly accelerating as 54% of lab networks reported using time-lapse incubation in at least some cycles in 2024 while complementary momentum shows up in growing clinic capacity with IVF clinic numbers up 3.5% year over year in 2022 and a measurable expansion of digital health use in trials, reaching 3.2% in 2021.
06 · Category
User Adoption4 stats
01
In 2023, 57% of fertility patients reported using internet sources to learn about IVF success rates (survey estimate)
02
In 2020, 41% of fertility patients reported using social media groups for peer support during treatment (survey estimate)
03
In 2021, 29% of ART clinics reported using embryo biopsy techniques as part of routine PGT workflows (practice survey figure)
04
In Germany, 56% of ART cycles used single embryo transfer in 2020 (Federal statistics/registry report figure)
Interpretation
User Adoption Interpretation
From the user adoption perspective, fertility patients are increasingly turning to digital platforms, with 57% using internet sources for IVF success rates in 2023 and 41% using social media groups for peer support in 2020, while clinic practices are also aligning as more ART cycles move toward standardized approaches like single embryo transfer at 56% in Germany in 2020.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Infertile Statistics. Gitnux. https://gitnux.org/infertile-statistics
MLA
Sophie Moreland. "Infertile Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/infertile-statistics.
Chicago
Sophie Moreland. 2026. "Infertile Statistics." Gitnux. https://gitnux.org/infertile-statistics.
Sources & references
51 datasets cited across this report · attribution is report-level
+25 additional datasets cited (not shown individually)